Saudi Arabia says OPEC will maintain its current oil production no matter what—until crude hits $40, Breitling Energy' Chris Faulkner said.» Read More
David Levin, McGraw-Hill Education CEO, discusses McGraw-Hill's plans to usher in a new era of digital education. We are seeing an opportunity to improve outcomes with technology, says Levin.
More bad news for President Obama, according to a new NBC/Wall Street Journal poll, the president's approval rating hit a new low. CNBC's Eamon Javers has the latest result on how Americans feel about President Obama, Congress, and the economy.
Tony Wible, Janney Capital Markets, breaks down the numbers on Disney's blockbuster quarter. I think the biggest thing is they are building new franchises, says Wible, commenting on Disney's studios.
Joe Kinahan, TD Ameritrade chief strategist, and Doug Cote, ING Investment Management, provide market strategies on the heels of Tuesday's market slide. The prospect of rising rates is what drove the sell-off on Tuesday, says Cote.
Target lowers its outlook as the data breach hurt sales; however, there are other factors at play as well.
Are Target's troubles merely anomalies, or symptomatic of the economy's problems, despite strong earnings reports?
CNBC's Jim Cramer shares his thoughts on Target. Basically it's a yield play at this point, says Cramer.
Our fastest-growing market this year is the Jersey shore, says Brian Sharples, HomeAway CEO, providing his read on the short-term summer rental business and the latest travel trends.
Neel Kashkari, (R-Calif.) gubernatorial candidate, provides his take on the nation's economic recovery.
Jan Kniffen, J. Rogers Kniffen Worldwide Enterprises, says price competition with Wal-Mart, not the data breach is the reason Target lowered its profit margins.
Neel Kashkari—GOP candidate for governor of California—delivered on CNBC a scathing critique of President Barack Obama and Democratic policies in D.C.
Target warned of higher expenses related to its data breach on Tuesday and cut its second-quarter profit outlook.
Trevor Fetter, Tenet Healthcare CEO, discusses "compassionate use" drug therapies. It is really not in the realm of what we do in our company, says Fetter.
Trevor Fetter, Tenent Healthcare CEO, breaks down the company's better-than-expected second quarter results, Obamacare, and the acquisition of Vanguard. Also Fetter discusses the growing trend to treat patients outside the hospital.
Daniel Alpert, Westwood Capital managing director, explains why the current growth rate in the U.S. economy is likely to put downward pressure on stocks.
NBC's Jim Maceda reports on the efforts to end the fighting in Gaza and set the stage for talks in Egypt to reach a broader deal on a sustainable truce.
Scott Gottlieb, M.D., American Enterprise Institute, and Jeff Allen, Friends of Cancer Research executive director, discuss the FDA's drug approval process and the need in some cases to allow access to experimental therapies.
Nathan Traller, father of young cancer patient Nathalie Traller, discusses the compassionate use of experimental drugs for patients.
CNBC's Meg Tirrell explains how compassionate use works and why it's the center of a lot of controversy.
Anthony DiClemente, Nomura Securities senior analyst, provides a preview of Disney's third quarter earnings and discusses the key drivers for growth. The parks are on fire here, points out DiClemente.
Get the best of CNBC in your inbox